The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM): Methods, design, and sample characteristics

American Journal of Epidemiology

Volumn 163, Issue 9, 2006, Pages 860-869

  Tien, Phyllis C ^a,b   Benson, Constance ^c   Zolopa, Andrew R ^d   Sidney, Stephen ^e   Osmond, Dennis ^a   Grunfeld, Carl ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DIVISION OF RESEARCH   (United States)

Author keywords

Body fat distribution; Dyslipidemias; HIV infections; Insulin resistance; Lipodystrophy; Metabolism

Indexed keywords

CARDIOVASCULAR DISEASE; FAT; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; POPULATION DYNAMICS; VIRAL DISEASE;

ADULT; ANTHROPOMETRY; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY DISTRIBUTION; BODY FAT; CAROTID ARTERY; DEMOGRAPHY; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INSULIN RESISTANCE; LABORATORY DIAGNOSIS; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC REGULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; SAMPLING; SYMPTOM;

ADIPOSE TISSUE; ADIPOSITY; ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HIV; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; LIPODYSTROPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WHOLE BODY IMAGING;

NORTH AMERICA; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33646244053     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj111     Document Type: Article

References (33)

1. Can A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
2. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999;13:2493-505.
3. Tien PC, Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis 2004;17:27-32.
4. Saint-Marc T, Partisani M, Poizot-Martin I, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO Study. AIDS 2000;14:37-49.
5. Martinez E, Mocroft A, Garcia-Viejo MA, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001;357:592-8.
6. Galli M, Cozzi-Lepri A, Ridolfo AL, et al. Incidence of adipose tissue alterations in first-line antiretroviral therapy: The LipoICoNa Study. Arch Intern Med 2002;162:2621-8.
7. Galli M, Veglia F, Angarano G, et al. Gender differences in antiretroviral drug-related adipose tissue alterations. J Acquir Immune Defic Syndr 2003;34:58-61.
8. Saves M, Raffi F, Capeau J, et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2002;34:1397-405.
9. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-18.
10. Madge S, Kinloch-de-Loes S, Mercey D, et al. Lipodystrophy in patients naive to HIV protease inhibitors. AIDS 1999;13:735-7.
11. Gervasoni C, Ridolfo AL, Trifiro G, et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 1999;13:465-71.
12. Dong KL, Bausserman LL, Flynn MM, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr 1999;21:107-13.
13. Lichtenstein K, Delaney K, Armon C, et al. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1 infected patients. J Acquir Immune Defic Syndr 2003;32:48-56.
14. Mallal SA, John M, Moore CB, et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000;14:1309-16.
15. Lo JC, Mulligan K, Tai VW, et al. "Buffalo hump" in men with HIV-1 infection. Lancet 1998;351:867-70.
16. Miller KK, Daly PA, Sentochnik D, et al. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;27:68-72.
17. Miller KD, Jones E, Yanovski JA, et al. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871-5.
18. Grunfeld C, Kotler DP, Hamadeh R, et al. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989;86:27-31.
19. Grunfeld C, Pang M, Doerrler W, et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045-52.
20. Hughes GH, Cutter G, Donahue R, et al. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) Study. Control Clin Trials 1987;8(suppl):68S-73S.
21. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
22. Hill JO, Sidney S, Lewis CE, et al. Racial differences in amounts of visceral adipose tissue in young adults: The CARDIA (Coronary Artery Risk Development in Young Adults) Study. Am J Clin Nutr 1999;69:381-7.
23. Sidney S, Jacobs DR Jr, Haskell WL, et al. Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 1991;133:1231-45.
24. Hoegerman GS, Lewis CE, Flack J, et al. Lack of association of recreational cocaine and alcohol use with left ventricular mass in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Am Coll Cardiol 1995;25:895-900.
25. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-70.
26. Gallagher D, Belmonte D, Deurenberg P, et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol 1998;275:E249-58.
27. Shen W, Wang Z, Tang H, et al. Volume estimates by imaging methods: model comparisons with visible woman as the reference. Obes Res 2003;11:217-25.
28. O'Leary DH, Polak JF, Wolfson SK Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22:1155-63.
29. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998;339:1897-904.
30. National Center for Health Statistics. The Third National Health and Nutrition Examination Survey (NHANES III, 1988-94) reference manuals and reports - October 1996. (CD-ROM). Hyattsville, MD: National Center for Health Statistics, 1996. (Available from the National Technical Information Service, Springfield, Virginia).
31. Palella FJ Jr, Cole SR, Chmiel JS, et al. Anthropometrics and examiner-reported body habitus abnormalities in the Multicenter AIDS Cohort Study. Clin Infect Dis 2004;38:903-7.
32. Tien PC, Cole SR, Williams CM, et al. Incidence of lipoatrophy and lipohypertrophy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2003;34:461-6.
33. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001;15:1389-98.